AURICULARUM, powder and solvent for suspension ear drops bottle, 10 ml
Active ingredients: Dexamethasone sodium phosphate, Nystatin, Oxytetracycline hydrochloride, Polymyxin b1 sulfate
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for suspension for instillationbottle, 10 mlauriculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AURICULARUM, poudre et solvant pour suspension pour instillation auriculaire
- Pharmaceutical form
- poudre et solvant pour suspension pour instillation
- Route of administration
- auriculaire
- Presentation description
- 1 flacon(s) polyéthylène de poudre - 1 ampoule(s) polyéthylène basse densité (PEBD) de 10 ml de solvant
- Marketing authorisation holder
- GRIMBERG
- Reimbursement according to BDPM
- 15 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 26 Feb 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66592652CIP73019225CIP133400930192252Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| NYSTATINEpoudre | 1 000 000 UI · un flacon | SA |
| SULFATE DE POLYMYXINE Bpoudre | 12,3 mg · un flacon | SA |
| DEXAMÉTHASONE (PHOSPHATE SODIQUE DE)poudre | 10 mg · un flacon | SA |
| OXYTÉTRACYCLINE (CHLORHYDRATE D')poudre | 100 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.